789 results on '"Tan, Aaron"'
Search Results
52. Identifying correlates of post treatment responses for unresectable locally advanced non-small cell lung cancer (LA NSCLC).
53. P30 A longitudinal perspective of antimicrobial resistance evolution within urinary tract infection-based clinical trials
54. A transcriptome-wide meta-analysis reveals lack of cancer-cell intrinsic determinants of response to immune checkpoint blockade
55. Dearth of smoking-induced mutations in NSRO-driven non-small-cell lung cancer despite smoking exposure
56. Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study—An Asian Tertiary Cancer Center Experience
57. Structural insights into HIV-1 polyanion-dependent capsid lattice formation revealed by single particle cryo-EM
58. Two structural switches in HIV-1 capsid regulate capsid curvature and host factor binding
59. Treatment of Laser-Responsive Dermal Pigmentary Conditions in Type III-IV Asian Skin With a 755-nm Picosecond Pulse Duration Laser: A Retrospective Review of Its Efficacy and Safety
60. Pharmaceuticals and Stem Cells in Autism Spectrum Disorders: Wishful Thinking?
61. The Palgrave Handbook of Asian Cinema
62. Deep learning model to identify homonymous defects on automated perimetry.
63. Implementation of the South Australian Regional Telestroke service is associated with improved care quality and lower stroke mortality: A retrospective cohort study.
64. Supplementary Data from Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
65. Evasion of toll-like receptor recognition by Escherichia coli is mediated via population level regulation of flagellin production
66. The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice
67. Exploits of an Evil Queen
68. First-line ALK inhibitors in treatment-naive advanced ALK rearranged non-small cell lung cancer: systematic review and network meta-analysis
69. Unraveling the Impact of Intratumoral Heterogeneity on EGFR Tyrosine Kinase Inhibitor Resistance in EGFR-Mutated NSCLC
70. A Familiar Villain
71. Deep Reinforcement Learning for Decentralized Multi-Robot Exploration With Macro Actions
72. Ultra-Long Transfers for Endovascular Thrombectomy—Mission Impossible?: The Australia-New Zealand Experience
73. Self-assembly and sequence length dependence on nanofibrils of polyglutamine peptides
74. Next generation covered stents made from nanocomposite materials: A complete assessment of uniformity, integrity and biomechanical properties
75. Nanotechnology and regenerative therapeutics in plastic surgery: The next frontier
76. Preventing in-stent restenosis using lipoprotein (a), lipid and cholesterol adsorbent materials
77. Awareness, attitude and willingness regards cadaveric organ donation and awareness of brain death among Sarawakians in Kuching, Malaysia
78. Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates
79. Structural insights into HIV-1 polyanion-dependent capsid lattice formation revealed by single particle cryo-EM
80. Two structural switches in HIV-1 capsid regulate capsid curvature and host factor binding
81. Immunotherapy with chemotherapy and anti-angiogenic therapy for EGFR mutated NSCLC: challenging the dogma
82. Harnessing the disruption on medical trainee education due to COVID-19 in New South Wales, Australia
83. The Stolen Aztec Treasures
84. The Downfall of Two Kings
85. Immune Checkpoint Inhibitors for Brain Metastases
86. Immune Checkpoint Inhibitors in Gliomas
87. Enhancing the electrical conductivity of a hybrid POSS–PCL/graphene nanocomposite polymer
88. Regenerative nanotechnology in oral and maxillofacial surgery
89. TOP AI INFRASTRUCTURE CONSIDERATIONS.
90. Red Hat CEO on OpenShift evolution and AI.
91. Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC)
92. Deep learning model to identify homonymous defects on automated perimetry
93. The Role of Liquid Biopsy in the Diagnostic Testing Algorithm for Advanced Lung Cancer
94. pH-Sensitive nano-systems for drug delivery in cancer therapy
95. Exosomes as Immunotheranostic Nanoparticles
96. Agent-Based Model for Decision Support in Multi-Site Manufacturing Enterprises
97. Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor‐positive breast cancer
98. About the Authors
99. The rise and rise of open source in China.
100. Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.